GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (STU:4RY) » Definitions » FFO per Share

Akeso (STU:4RY) FFO per Share


View and export this data going back to 2020. Start your Free Trial

What is Akeso FFO per Share?

FFO per Share only applies to REITs.


Akeso Business Description

Traded in Other Exchanges
Address
6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in USA.